Evidence map›Paper›PMID 36798113›Full record

ArticleF1000Research2022

Entry of the antipsychotic drug, olanzapine, into the developing rat brain in mono- and combination therapies.

Yifan Huang, Fiona Qiu, Mark Habgood, Shuai Nie, Katarzyna Dziegielewska, Norman Saunders

Open access · goldAbstract read
In one paragraph

Article in F1000Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Choroid Plexus Pathophysiology.Annual review of pathology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Yifan HuangDepartment of Neuroscience, Monash University, Melbourne, Victoria, 3004, Australia.ORCID 0000-0003-1060-3668
Fiona QiuDepartment of Neuroscience, Monash University, Melbourne, Victoria, 3004, Australia.
Mark HabgoodDepartment of Neuroscience, Monash University, Melbourne, Victoria, 3004, Australia.
Shuai NieMelbourne Mass Spectrometry and Proteomics Facility, Bio 21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, 3010, Australia.
Katarzyna DziegielewskaDepartment of Neuroscience, Monash University, Melbourne, Victoria, 3004, Australia.
Norman SaundersDepartment of Neuroscience, Monash University, Melbourne, Victoria, 3004, Australia.
The University of Melbourne · AUMonash University · AUBiotechnology Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antipsychotic AgentsAcetaminophenAnimalsBrainCimetidineDigoxinFemaleLamotrigineOlanzapinePharmaceutical PreparationsPlacentaPregnancyRatsRats, Sprague-DawleyAcetaminophenAntipsychotic AgentsCimetidineDigoxinLamotrigineOlanzapinePharmaceutical Preparationsblood brain barriercerebrospinal fluidchoroid plexusdrug interactiondrug transferolanzapineP-glycoproteinplacental barrier

Identifiers

PMID36798113
PMCPMC9925881.2
OpenAlexW4310828050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.